KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Debt Ratio (2017 - 2026)

Amneal Pharmaceuticals has reported Debt Ratio over the past 9 years, most recently at 0.7 for Q4 2025.

  • For Q4 2025, Debt Ratio rose 7.96% year-over-year to 0.7; the TTM value through Dec 2025 reached 0.7, up 7.96%, while the annual FY2025 figure was 0.7, 7.96% up from the prior year.
  • Debt Ratio for Q4 2025 was 0.7 at Amneal Pharmaceuticals, down from 0.71 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.74 in Q1 2024 and troughed at 0.02 in Q1 2021.
  • A 5-year average of 0.66 and a median of 0.69 in 2022 define the central range for Debt Ratio.
  • On a YoY basis, Debt Ratio climbed as much as 4143.71% in 2021 and fell as far as 97.59% in 2021.
  • Year by year, Debt Ratio stood at 0.69 in 2021, then increased by 0.3% to 0.69 in 2022, then grew by 0.99% to 0.7 in 2023, then decreased by 7.31% to 0.65 in 2024, then increased by 7.96% to 0.7 in 2025.
  • Business Quant data shows Debt Ratio for AMRX at 0.7 in Q4 2025, 0.71 in Q3 2025, and 0.64 in Q2 2025.